MedCity News January 14, 2021
Metagenomics applied in a rapid clinical setting was unthinkable just a few years ago but now can be deployed by any hospital with local deployment.
With more than 1.8 million Covid-19-related deaths worldwide and more than 350,000 deaths in the United States alone, the battle against SARS-CoV-2 is raging on into 2021.
In 2020, we’ve certainly learned that better infrastructure for detection is critical in fighting diseases like Covid-19 – and metagenomics are key to better understanding and ultimately better treatment. As a consulting infectious disease physician and frontline worker, I’ve seen the battle first-hand and there is still a lot of work to do. I was lucky to get the recently after seeing patients but we are still...
Today's Sponsors
Today's Sponsor